CCRC yields 30.77% · PFE yields 6.20%● Live data
📍 CCRC pulled ahead of the other in Year 1
Combined, CCRC + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CCRC + PFE for your $10,000?
China Customer Relations Centers, Inc. is a business process outsourcing service provider company, which focuses on the voice-based customer care services including inbound and outbound. The company is headquartered in Taian, Shandong and currently employs 11,101 full-time employees. The firm's customers are the provincial subsidiaries of various telecommunications carriers in the PRC. The company also provides outsourcing services to its clients whereby they can lease its employees to work at their offices. The firm operates its business through contractual arrangements between its subsidiary, wholly foreign owned enterprise (WFOE) and its variable interest entity, Shandong Taiying Technology Co., Ltd (Taiying). Its line of services includes Inbound Customer Care Service and Outbound Customer Care Service. The firm's inbound customer support service offers answering service hotlines in China, round the clock.
Full CCRC Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.